These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9200947)

  • 21. Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosis.
    Léger OJ; Yednock TA; Tanner L; Horner HC; Hines DK; Keen S; Saldanha J; Jones ST; Fritz LC; Bendig MM
    Hum Antibodies; 1997; 8(1):3-16. PubMed ID: 9265500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characterization of neutralizing activity of murine monoclonal antibodies for construction of anti-human TNF chimeric antibody].
    Zhu CS; Ouyang WM; Liu XS; Cao YX; Zhao N; Jin BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Nov; 19(6):576-9. PubMed ID: 15182654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-CD4 monoclonal antibody therapy.
    Delmonico FL; Cosimi AB
    Clin Transplant; 1996 Oct; 10(5):397-403. PubMed ID: 8930451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1.
    Walker RE; Spooner KM; Kelly G; McCloskey RV; Woody JN; Falloon J; Baseler M; Piscitelli SC; Davey RT; Polis MA; Kovacs JA; Masur H; Lane HC
    J Infect Dis; 1996 Jul; 174(1):63-8. PubMed ID: 8656014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
    Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M
    J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical effects of a chimeric anti-EpCAM monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor in patients with metastatic colorectal carcinoma.
    Liljefors M; Nilsson B; Fagerberg J; Ragnhammar P; Mellstedt H; Frödin JE
    Int J Oncol; 2005 Jun; 26(6):1581-9. PubMed ID: 15870873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A therapeutic anti-CD4 monoclonal antibody inhibits T cell receptor signal transduction in mouse autoimmune cardiomyopathy.
    Wang ZH; Liao YH; Yuan J; Zhang L; Wang M; Zhang JH; Liu ZP; Dong JH
    Chin Med J (Engl); 2007 Aug; 120(15):1319-25. PubMed ID: 17711737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mAbs in nonlupus autoimmune rheumatic disease.
    Whelan BR; Isenberg DA
    Curr Opin Hematol; 2009 Jul; 16(4):280-4. PubMed ID: 19444098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Infliximab(chimeric monoclonal antibody to tumor necrosis factor alpha)].
    Hibi T; Yoshizawa S
    Nihon Rinsho; 2002 Mar; 60(3):480-6. PubMed ID: 11904962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis.
    Wendling D; Racadot E; Wijdenes J; Sibilia J; Flipo RM; Cantagrel A; Miossec P; Eschard JP; Macro M; Bertin P; Lioté F; Debiais F; Juvin R; Le Goff P; Masson C
    J Rheumatol; 1998 Aug; 25(8):1457-61. PubMed ID: 9712083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis.
    Coppieters K; Dreier T; Silence K; de Haard H; Lauwereys M; Casteels P; Beirnaert E; Jonckheere H; Van de Wiele C; Staelens L; Hostens J; Revets H; Remaut E; Elewaut D; Rottiers P
    Arthritis Rheum; 2006 Jun; 54(6):1856-66. PubMed ID: 16736523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fully human anti TNF-alpha monoclonal antibodies (adalimumab, golimumab)].
    Hirohata S
    Nihon Rinsho; 2007 Jul; 65(7):1202-8. PubMed ID: 17642233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic human monoclonal antibodies in inflammatory diseases.
    Kotsovilis S; Andreakos E
    Methods Mol Biol; 2014; 1060():37-59. PubMed ID: 24037835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Monoclonal antibodies in chronic autoimmune inflammatory diseases].
    Semerano L; Boissier MC
    Med Sci (Paris); 2009 Dec; 25(12):1108-12. PubMed ID: 20035687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TRU-015, a fusion protein derived from an anti-CD20 antibody, for the treatment of rheumatoid arthritis.
    Rubbert-Roth A
    Curr Opin Mol Ther; 2010 Feb; 12(1):115-23. PubMed ID: 20140823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Burns WH; Prendergast RA
    Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):246-50. PubMed ID: 8550330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fully human antibodies from transgenic mouse and phage display platforms.
    Lonberg N
    Curr Opin Immunol; 2008 Aug; 20(4):450-9. PubMed ID: 18606226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CD4 therapy in rheumatoid arthritis.
    Choy EH; Kingsley GH
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S147-9. PubMed ID: 8100751
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunotherapy of autoimmune disease with anti-T cell antibodies.
    Sriram S
    Concepts Immunopathol; 1989; 7():162-72. PubMed ID: 2676177
    [No Abstract]   [Full Text] [Related]  

  • 40. New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency.
    Velders MP; Litvinov SV; Warnaar SO; Gorter A; Fleuren GJ; Zurawski VR; Coney LR
    Cancer Res; 1994 Apr; 54(7):1753-9. PubMed ID: 8137290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.